HLX-011 · GLP-1 & metabolic
Retatrutide
LY3437943
Not dispatched to France or the United Kingdom. No pens or cartridges.
157 in Union stock14:00 Union cut-off
CoA for HLX-RETATR-2609-A is listed on
This week's lot · 25 vials remaining in the Union warehouse
Skip, pause or cancel any shipment. Laboratories only — not a protocol.
ex VAT
84,48 €
96,00 €
−12% · Union dispatch included
Code WELCOME10 is 15% on a first order over €40. SEPA / open banking / BTC another 5%.
lyophilised
Retatrutide is a synthetic 39-residue triple agonist at the GIP, GLP-1 and glucagon receptors, studied in laboratory research for comparative incretin-receptor pharmacology and cAMP signalling bias in transfected cell models. Supplied as a lyophilised sodium-salt powder for controlled research use.
Sequence
39-residue GIP/GLP-1/glucagon triple agonist; proprietary sequence — see COADispatch, VAT, reconstitution
- Cut-off 14:00 Union, 2–5 working days, DHL/DPD.
- EUR prices ex VAT. 21% unless a valid EU VAT ID on an ICS.
- Free Union dispatch from €250. FREESHIP from €80.
- No reconstitution or injection advice. Laboratory use only.
Not for human or veterinary use. Not a medicinal product. Invoiced in EUR, ex VAT.
Lot file before checkout
Five things on the lot file
HLX-RETATR-2609-A
Purity
≥98% HPLC
The tall peak is the named compound. The small rises are everything else in the vial. That difference is HPLC purity — a number, not a badge. It is not net peptide content.
Lot notes
Carton arrived, CoA matches the lot on the vial. Not a result. Not a protocol.
No signed-in notes on this lot yet.
Literature on the substance
- NEJM 2023 · Triple-hormone-receptor agonist retatrutide in obesity (phase 2)
PubMed-indexed papers about the molecule, not about this shop.
